Skip to main content

Table 2 Hazard ratios and coefficients of DFS-related ARGs

From: The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Gene

Hazard ratio

95%CI

Coefficient

p-value

VAV2

2.50

1.64–3.80

3.3924

 < 0.05

NRP1

2.41

1.58–3.70

0.5622

PRG2

2.31

1.51–3.54

1.1902

JAG2

2.13

1.39–3.27

0.3202

LPL

1.85

1.23–2.80

- 0.0801

POSTN

1.77

1.17–2.69

0.3631

FSTL1

1.76

1.17–2.69

0.7902

PF4

1.75

1.14–2.69

0.6997

JAG1

1.75

1.15–2.67

0.2249

COL3A1

1.73

1.14–2.62

0.3681

OLR1

1.65

1.08–2.52

− 0.0198

VEGFA

1.58

1.01–2.49

0.1602

VTN

1.56

1.03–2.36

0.0476

S100A4

1.96

1.17–3.29

0.9752

FGFR1

0.60

0.39–0.92

− 1.1699

LRPAP1

0.59

0.39–0.89

1.1291

CXCL6

0.57

0.37–0.89

− 0.1911

SERPINA5

0.52

0.34–0.78

− 0.4216

APP

0.46

0.30–0.71

− 0.3995

  1. DFS disease-free survival, CI confidence interval, NA not applicable